Chimeric Antigen Receptor T-cells for The Treatment of AML Expressing CLL-1 Antigen
Clinical trial NCT04219163 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT04219163
- Sponsor
- Baylor College of Medicine
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2020-07-09
- Primary completion
- 2025-03-24
- Enrollment
- 18
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.